Zhejiang Jianfeng Group Co., Ltd. (ZHEJIANG JIANFENG GROUP) aksje

Zhejiang Jianfeng Group Co., Ltd. engages in the building materials and medicine business in China. It provides pharmaceutical products, hazardous chemicals, and pharmaceutical excipients and packaging materials, as well as pesticides and pharmaceutical chemical intermediates. The company also offers cement, cement products, building materials, crushed stones, woven bags, ordinary Portland, clinker and commercial concrete, limestone, artificial sand, and aggregates, as well as non-metallic mineral products. In addition, it is involved in the mining and sale of limestone, sandstone, and shale for cement ingredients; disposal of solid waste and hazardous waste from cement kilns; and cement grinding and export trade. Further, the company provides drugs covering therapeutic areas, including antidepressant, antihypertensive, ant-infection, anti-inflammatory and anti-rheumatic, antiviral, ophthalmic, immunosuppressant, blood stasis dispelling and chest expansion agent, protein kinase inhibitors, anti-infective ophthalmic medication, protein pump inhibitor, and nervous system drugs – analgesics. Additionally, it offers Rhodiola rosea cracked spore powder soft capsules, cracked spore powder, Gutai capsules, Wanan soft capsules, and other health products. Zhejiang Jianfeng Group Co., Ltd. was founded in 1958 and is based in Jinhua, China.